MedTrace Logo

Atrial Fibrillation Risk After Miniinvasive Mitral Valve Repair

NCT06707506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2024-11-27

No results posted yet for this study

Summary

This retrospective cohort study investigates how CT-derived tissue quality parameters, serving as markers of metabolic status, predict post-operative atrial fibrillation risk in patients undergoing minimally invasive mitral valve surgery. The study leverages established associations between adipose tissue characteristics and metabolic dysfunction to explore their potential role in post-surgical arrhythmogenesis.

Conditions

Sponsors & Collaborators

  • Nemocnice AGEL Trinec-Podlesi a.s.

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2023-11-30
Completion
2024-08-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06707506 on ClinicalTrials.gov